Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Changes in the lipidome in type 1 diabetes following low carbohydrate diet : Post-hoc analysis of a randomized crossover trial. / Al-Sari, Naba; Schmidt, Signe; Suvitaival, Tommi; Kim, Min; Trošt, Kajetan; Ranjan, Ajenthen G.; Christensen, Merete B.; Overgaard, Anne J.; Pociot, Flemming; Nørgaard, Kirsten; Legido-Quigley, Cristina.

In: Endocrinology, Diabetes and Metabolism, Vol. 4, No. 2, e00213, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Al-Sari, N, Schmidt, S, Suvitaival, T, Kim, M, Trošt, K, Ranjan, AG, Christensen, MB, Overgaard, AJ, Pociot, F, Nørgaard, K & Legido-Quigley, C 2021, 'Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial', Endocrinology, Diabetes and Metabolism, vol. 4, no. 2, e00213. https://doi.org/10.1002/edm2.213

APA

Al-Sari, N., Schmidt, S., Suvitaival, T., Kim, M., Trošt, K., Ranjan, A. G., Christensen, M. B., Overgaard, A. J., Pociot, F., Nørgaard, K., & Legido-Quigley, C. (2021). Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial. Endocrinology, Diabetes and Metabolism, 4(2), [e00213]. https://doi.org/10.1002/edm2.213

Vancouver

Al-Sari N, Schmidt S, Suvitaival T, Kim M, Trošt K, Ranjan AG et al. Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial. Endocrinology, Diabetes and Metabolism. 2021;4(2). e00213. https://doi.org/10.1002/edm2.213

Author

Al-Sari, Naba ; Schmidt, Signe ; Suvitaival, Tommi ; Kim, Min ; Trošt, Kajetan ; Ranjan, Ajenthen G. ; Christensen, Merete B. ; Overgaard, Anne J. ; Pociot, Flemming ; Nørgaard, Kirsten ; Legido-Quigley, Cristina. / Changes in the lipidome in type 1 diabetes following low carbohydrate diet : Post-hoc analysis of a randomized crossover trial. In: Endocrinology, Diabetes and Metabolism. 2021 ; Vol. 4, No. 2.

Bibtex

@article{f4ff987af9ef43ec9d3d7a14e173008b,
title = "Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial",
abstract = "Aims: Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes. Methods: Ten adults with type 1 diabetes (mean ± SD: age 43.6 ± 13.8 years, diabetes duration 24.5 ± 13.4 years, BMI 24.9 ± 2.1 kg/m2, HbA1c 57.6 ± 2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day), respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models. Results: In total, 289 lipid species were identified from 14 major lipid classes. Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β ± SE: 1.44 ± 0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β ± SE: 1.34 ± 0.25, FDR = 0.009) species. Polyunsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Conclusion: Lipidome-wide outcome analysis of a randomized crossover trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The polyunsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Results from this study warrant for more investigation on the long-term effect of single lipid species in type 1 diabetes.",
keywords = "cardiovascular disease, dyslipidaemia, lipidomics, low carbohydrate diet, randomized trial, type 1 diabetes",
author = "Naba Al-Sari and Signe Schmidt and Tommi Suvitaival and Min Kim and Kajetan Tro{\v s}t and Ranjan, {Ajenthen G.} and Christensen, {Merete B.} and Overgaard, {Anne J.} and Flemming Pociot and Kirsten N{\o}rgaard and Cristina Legido-Quigley",
year = "2021",
doi = "10.1002/edm2.213",
language = "English",
volume = "4",
journal = "Endocrinology, Diabetes and Metabolism",
issn = "2398-9238",
publisher = "Wiley",
number = "2",

}

RIS

TY - JOUR

T1 - Changes in the lipidome in type 1 diabetes following low carbohydrate diet

T2 - Post-hoc analysis of a randomized crossover trial

AU - Al-Sari, Naba

AU - Schmidt, Signe

AU - Suvitaival, Tommi

AU - Kim, Min

AU - Trošt, Kajetan

AU - Ranjan, Ajenthen G.

AU - Christensen, Merete B.

AU - Overgaard, Anne J.

AU - Pociot, Flemming

AU - Nørgaard, Kirsten

AU - Legido-Quigley, Cristina

PY - 2021

Y1 - 2021

N2 - Aims: Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes. Methods: Ten adults with type 1 diabetes (mean ± SD: age 43.6 ± 13.8 years, diabetes duration 24.5 ± 13.4 years, BMI 24.9 ± 2.1 kg/m2, HbA1c 57.6 ± 2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day), respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models. Results: In total, 289 lipid species were identified from 14 major lipid classes. Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β ± SE: 1.44 ± 0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β ± SE: 1.34 ± 0.25, FDR = 0.009) species. Polyunsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Conclusion: Lipidome-wide outcome analysis of a randomized crossover trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The polyunsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Results from this study warrant for more investigation on the long-term effect of single lipid species in type 1 diabetes.

AB - Aims: Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes. Methods: Ten adults with type 1 diabetes (mean ± SD: age 43.6 ± 13.8 years, diabetes duration 24.5 ± 13.4 years, BMI 24.9 ± 2.1 kg/m2, HbA1c 57.6 ± 2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day), respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models. Results: In total, 289 lipid species were identified from 14 major lipid classes. Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β ± SE: 1.44 ± 0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β ± SE: 1.34 ± 0.25, FDR = 0.009) species. Polyunsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Conclusion: Lipidome-wide outcome analysis of a randomized crossover trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The polyunsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL cholesterol (p <.001). Results from this study warrant for more investigation on the long-term effect of single lipid species in type 1 diabetes.

KW - cardiovascular disease

KW - dyslipidaemia

KW - lipidomics

KW - low carbohydrate diet

KW - randomized trial

KW - type 1 diabetes

U2 - 10.1002/edm2.213

DO - 10.1002/edm2.213

M3 - Journal article

C2 - 33855215

AN - SCOPUS:85099025530

VL - 4

JO - Endocrinology, Diabetes and Metabolism

JF - Endocrinology, Diabetes and Metabolism

SN - 2398-9238

IS - 2

M1 - e00213

ER -

ID: 255353274